These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2894215)

  • 21. Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin.
    Zehender M; Meinertz T; Hohnloser S; Geibel A; Hartung J; Seiler KU; Just H
    Am J Cardiol; 1989 Apr; 63(12):826-32. PubMed ID: 2648788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen.
    Radack KL; Deck CC; Bloomfield SS
    Ann Intern Med; 1987 Nov; 107(5):628-35. PubMed ID: 2889416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind comparison of ketanserin with placebo in patients with essential hypertension.
    Wellens D; Peeters G; Baeten B; Sieben G; Symoens J
    Angiology; 1986 Nov; 37(11):810-7. PubMed ID: 3538945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects during therapy with the serotonin antagonist ketanserin.
    Distler A
    Clin Physiol Biochem; 1990; 8 Suppl 3():64-80. PubMed ID: 1983424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic and hemodynamic effects of antihypertensive treatment with ketanserin.
    Levinson PD; Zimlichman R; Goldstein DS; Brewer HB; Keiser HR
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):245S-248S. PubMed ID: 3415801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketanserin in essential hypertension: a double-blind, placebo-controlled study.
    Cameron HA; Ramsay LE
    Postgrad Med J; 1985 Jul; 61(717):583-6. PubMed ID: 3161013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
    Dixon MS; Thomas P; Sheridan DJ
    Eur J Clin Pharmacol; 1990; 38(1):21-4. PubMed ID: 1970298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled trial of ketanserin in hypertension.
    McGourty JC; Silas JH; Cowen KJ
    Br J Clin Pharmacol; 1985 Jul; 20(1):37-40. PubMed ID: 3161531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of once daily endralazine with placebo in the treatment of hypertension uncontrolled by a beta-blocker and diuretic.
    McGourty JC; Silas JH; Pidgeon J
    Eur J Clin Pharmacol; 1985; 29(4):401-3. PubMed ID: 2868900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group.
    BMJ; 1989 Feb; 298(6671):424-30. PubMed ID: 2495049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive efficacy of the combination of ketanserin + thiazide in hypertensives older than 50 years.
    Ferrara LA; Fasano ML; Soro S; Pasanisi F; Mancini M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S124-6. PubMed ID: 2446060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blocker.
    Abraham PA; Halstenson CE; Matzke GR; Napier JL; Keane WF
    Pharmacotherapy; 1985; 5(5):285-9. PubMed ID: 2866492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind study of the blood pressure lowering effect of a thiazide diuretic in hypertensive patients already on nifedipine and a beta-blocker.
    Cappuccio FP; Markandu ND; Tucker FA; Shore AC; MacGregor GA
    J Hypertens; 1987 Dec; 5(6):733-8. PubMed ID: 3429872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative antihypertensive effects of ketanserin and a ketanserin-hydrochlorothiazide combination administered once daily.
    Leary WP; Reyes AJ; van der Byl K; Maharaj B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S127-34. PubMed ID: 2446061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketanserin and captopril interaction in the treatment of essential hypertensives.
    Lavezzaro G; Ladetto PE; Valente M; Stramignoni D; Zanna C; Assogna G; Salvetti A
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():119-22. PubMed ID: 2285641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.
    Lewis R; Maclean D; Ioannides C; Johnston A; McDevitt DG
    Br J Clin Pharmacol; 1988 Jul; 26(1):53-9. PubMed ID: 2904825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of acebutolol and hydrochlorothiazide in essential hypertension.
    Lewis JE
    Am Heart J; 1985 May; 109(5 Pt 2):1168-74. PubMed ID: 2859781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.